Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2018-08-15 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
东海证券股份有限公司关于公司部分募集资金投资项目结项并将结余资金永久补充流动资金的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from Donghai Securities regarding the use of raised funds by Kuihua Pharmaceutical Group Co., Ltd. It discusses the completion of certain fundraising investment projects and the permanent supplementation of surplus funds into working capital. The text references regulatory guidelines, fundraising amounts, project statuses, board and supervisory committee approvals, independent director opinions, and the sponsor institution's opinion. It is not a full annual or interim financial report, nor an earnings release or call transcript. It is a formal verification or audit-related opinion on the use of funds raised in an IPO, which aligns with an Audit Report / Information (AR) category. The document length is 3365 characters, which is relatively short but contains substantive content rather than just an announcement. Therefore, it is best classified as an Audit Report / Information (AR). Q3 2018
2018-08-15 Chinese
独立董事关于公司第三届董事会第九次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on various company matters discussed at the third board's ninth meeting, including opinions on the 2018 half-year fundraising usage report, approval of funding reallocations, business proposals, auditor reappointment, accounting policy changes, external guarantees, and related party transactions. It references the 2018 half-year period and includes detailed opinions on financial and governance matters but does not contain full financial statements or comprehensive financial data typical of an Interim/Quarterly Report. Instead, it is a formal opinion document related to board meeting resolutions and compliance with regulations. This fits best under Board/Management Information (MANG), as it concerns board meeting matters and independent directors' opinions on company governance and financial issues discussed at the board meeting.
2018-08-15 Chinese
董事会关于2018年半年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2018 half-year special report on the deposit and actual use of raised funds" by the board of directors of a company. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange regarding the management and use of raised funds. The content details the amount of funds raised, their deposit, usage, management, and supervision, including tables showing the use and changes in investment projects funded by the raised capital. The document is a detailed report on the status and use of capital raised by the company, specifically for the half-year period ending June 30, 2018. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document is not an announcement of a report but the report itself, and it contains substantive financial data related to fundraising usage. Therefore, the appropriate classification is CAP.
2018-08-15 Chinese
关于变更公司会计政策的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about a change in its accounting policies, specifically referencing new accounting standards issued by the Ministry of Finance and their implementation. It details the nature of the accounting policy changes, their impact, and includes approvals from the board, independent directors, and supervisory board. The document is relatively short (2581 characters) and does not contain actual financial statements or detailed financial data. It is a formal disclosure about accounting policy changes rather than a full financial report or audit report. Therefore, it fits best as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2018-08-15 Chinese
关于续聘会计师事务所的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the reappointment of an accounting firm (瑞华会计师事务所) as the auditor for the company's 2018 financial audit. It includes details about the auditor's qualifications, the board's approval, and the independent directors' opinions. The document does not contain any actual audit report, financial statements, or detailed audit results. It is a formal announcement about the auditor appointment, not the audit report itself. The document length is short (1172 characters), and it serves as a notice to shareholders and the public about the auditor reappointment, which fits the category of Audit Report / Information (AR) as it relates to audit matters but is not a full annual report or audit report document. Therefore, the best classification is AR (Audit Report / Information). FY 2018
2018-08-15 Chinese
第三届监事会第五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of a company regarding the approval of the 2018 semi-annual report and related financial and operational matters. It includes voting results on various proposals such as the semi-annual report, use of raised funds, appointment of auditors, and accounting policy changes. The document does not contain the full semi-annual report itself but rather the Supervisory Board's approval and meeting resolutions. The document length is short (2048 characters) and it is an announcement of meeting decisions rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS) as it is a formal regulatory announcement of supervisory board resolutions and approvals related to the interim report and other corporate matters, not the interim report itself.
2018-08-15 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.